Back to Search
Start Over
Rhabdomyolysis due to rosuvastatin in a patient with ROHHAD syndrome.
- Source :
-
Journal of clinical lipidology [J Clin Lipidol] 2021 Nov-Dec; Vol. 15 (6), pp. 789-792. Date of Electronic Publication: 2021 Sep 10. - Publication Year :
- 2021
-
Abstract
- We report a 13-year-old female with rapid-onset obesity, hypothalamic dysfunction, hypoventilation, and autonomic dysregulation (ROHHAD) syndrome, panhypopituitarism, dyslipidemia, type 2 diabetes mellitus, and nonalcoholic fatty liver disease, who developed rhabdomyolysis and acute kidney injury, two weeks after switching from lovastatin to rosuvastatin. She had been on lovastatin for eight years without any adverse effects.<br />Competing Interests: Declaration of Competing Interest All the authors have no con-flicts of interest to disclose.<br /> (Copyright © 2021 National Lipid Association. Published by Elsevier Inc. All rights reserved.)
- Subjects :
- Abnormalities, Multiple pathology
Adolescent
Anticholesteremic Agents adverse effects
Anticholesteremic Agents therapeutic use
Autonomic Nervous System Diseases complications
Autonomic Nervous System Diseases drug therapy
Diabetes Mellitus, Type 2 complications
Female
Humans
Hypothalamic Diseases complications
Hypothalamic Diseases drug therapy
Hypoventilation complications
Hypoventilation drug therapy
Non-alcoholic Fatty Liver Disease complications
Obesity complications
Obesity drug therapy
Rosuvastatin Calcium therapeutic use
Syndrome
Abnormalities, Multiple drug therapy
Rhabdomyolysis chemically induced
Rhabdomyolysis diagnosis
Rosuvastatin Calcium adverse effects
Subjects
Details
- Language :
- English
- ISSN :
- 1933-2874
- Volume :
- 15
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- Journal of clinical lipidology
- Publication Type :
- Academic Journal
- Accession number :
- 34600840
- Full Text :
- https://doi.org/10.1016/j.jacl.2021.09.002